Hims & Hers Health Stock (NYSE:HIMS)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$27.78

52W Range

$13.74 - $70.43

50D Avg

$25.49

200D Avg

$33.66

Market Cap

$6.44B

Avg Vol (3M)

$27.20M

Beta

2.40

Div Yield

-

HIMS Company Profile


Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.

Show More

Industry

Medical - Equipment & Services

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

1,637

IPO Date

Sep 13, 2019

Website

HIMS Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25
Non-US$133.99M
UNITED STATES$2.21B

Fiscal year ends in Dec 25 | Currency in USD

HIMS Financial Summary


Dec 25Dec 24Dec 23
Revenue$2.35B$1.48B$872.00M
Operating Income$105.61M$61.90M$-29.45M
Net Income$128.37M$126.04M$-23.55M
EBITDA$105.61M$78.99M$-19.94M
Basic EPS$0.57$0.58$-0.11
Diluted EPS$0.51$0.53$-0.11

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 11, 26 | 12:00 AM
Q4 25Feb 23, 26 | 5:00 PM
Q3 25Nov 03, 25 | 5:00 PM

Peer Comparison


TickerCompany
PENPenumbra, Inc.
BAXBaxter International Inc.
TECHBio-Techne Corporation
MRNAModerna, Inc.
QGENQiagen N.V.
RVTYRevvity, Inc.
HQYHealthEquity, Inc.
ALGNAlign Technology, Inc.
ENSGThe Ensign Group, Inc.
BMRNBioMarin Pharmaceutical Inc.